Zobrazeno 1 - 10
of 174
pro vyhledávání: '"David, Busse"'
Autor:
Jörn Grensemann, David Busse, Christina König, Kevin Roedl, Walter Jäger, Dominik Jarczak, Stefanie Iwersen-Bergmann, Carolin Manthey, Stefan Kluge, Charlotte Kloft, Valentin Fuhrmann
Publikováno v:
Annals of Intensive Care, Vol 10, Iss 1, Pp 1-10 (2020)
Abstract Background Infection and sepsis are a main cause of acute-on-chronic liver failure (ACLF). Adequate dosing of antimicrobial therapy is of central importance to improve outcome. Liver failure may alter antibiotic drug concentrations via chang
Externí odkaz:
https://doaj.org/article/5d191904286d467089c35c2382ffdba5
Autor:
David Busse, Philipp Simon, David Petroff, Christoph Dorn, Lisa Schmitt, Davide Bindellini, Alexander Kratzer, Arne Dietrich, Markus Zeitlinger, Wilhelm Huisinga, Robin Michelet, Hermann Wrigge, Charlotte Kloft
Publikováno v:
Pharmaceutics, Vol 13, Iss 9, p 1380 (2021)
Precision dosing of piperacillin/tazobactam in obese patients is compromised by sparse information on target-site exposure. We aimed to evaluate the appropriateness of current and alternative piperacillin/tazobactam dosages in obese and nonobese pati
Externí odkaz:
https://doaj.org/article/c60f517415a54cfaa448b2b846e07843
Autor:
Philipp Simon, David Petroff, David Busse, Jana Heyne, Felix Girrbach, Arne Dietrich, Alexander Kratzer, Markus Zeitlinger, Charlotte Kloft, Frieder Kees, Hermann Wrigge, Christoph Dorn
Publikováno v:
Antibiotics, Vol 9, Iss 12, p 931 (2020)
Background: This controlled clinical study aimed to investigate the impact of obesity on plasma and tissue pharmacokinetics of meropenem. Methods: Obese (body mass index (BMI) ≥ 35 kg/m2) and age-/sex-matched nonobese (18.5 kg/m2 ≥ BMI ≤ 30 kg/
Externí odkaz:
https://doaj.org/article/6442c100172c4f1590ef2a4b1170fd99
Autor:
David Busse, Philipp Simon, Lisa Schmitt, David Petroff, Christoph Dorn, Arne Dietrich, Markus Zeitlinger, Wilhelm Huisinga, Robin Michelet, Hermann Wrigge, Charlotte Kloft
Publikováno v:
Clinical Pharmacokinetics. 61:655-672
Background and objectives: A quantitative evaluation of the PK of meropenem, a broad-spectrum ��-lactam antibiotic, in plasma and interstitial space fluid (ISF) of subcutaneous adipose tissue of obese patients is lacking as of date. The objective
Publikováno v:
Journal of Pharmaceutical Sciences. 109:2309-2320
The pharma industry designs increasingly less cytochrome P450 dependent and more metabolically stable drugs, and consequently UGT-metabolism becomes more frequently involved. This study compares 2 glucuronidation RAF-scaling approaches, product forma
Autor:
David Busse, Wilhelm Huisinga, Charlotte Kloft, Christoph Dorn, Jens Markus Borghardt, Alice Pevzner, Hermann Wrigge, Philipp Simon, David Petroff, Nahed El-Najjar
Aims: The most suitable method for predicting the glomerular filtration rate (GFR) in obesity is currently debated. Therefore, multiple GFR/creatinine clearance prediction methods were applied to (morbidly) obese and nonobese patients ranging from mo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::38b687e0c4b9022c4f0c8ccf3d03745b
https://refubium.fu-berlin.de/handle/fub188/33119
https://refubium.fu-berlin.de/handle/fub188/33119
Autor:
Torben Biester, Thomas Danne, Markus F. Scheerer, David W. Boulton, Weifeng Tang, Joanna Parkinson, Viktor Sokolov, David Busse
Publikováno v:
Br J Clin Pharmacol
Aims To quantitatively compare pharmacokinetics (PK) and the exposure-response (ER) relationship of the sodium-glucose cotransporter-2 inhibitor, dapagliflozin, between adolescents/young adults and adults with type 1 diabetes mellitus (T1DM). Methods
Autor:
David Petroff, Christoph Dorn, Wilhelm Huisinga, David Busse, Lisa Schmitt, Philipp Simon, Arne Dietrich, Alexander Kratzer, Charlotte Kloft, Robin Michelet, Hermann Wrigge, Davide Bindellini, Markus Zeitlinger
Publikováno v:
Pharmaceutics, Vol 13, Iss 1380, p 1380 (2021)
Pharmaceutics
Volume 13
Issue 9
Pharmaceutics
Volume 13
Issue 9
Precision dosing of piperacillin/tazobactam in obese patients is compromised by sparse information on target-site exposure. We aimed to evaluate the appropriateness of current and alternative piperacillin/tazobactam dosages in obese and nonobese pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd3c064973558d2fdbba3aa56300e4fd
Autor:
Alexander Kratzer, Arne Dietrich, Felix Girrbach, Philipp Simon, Hermann Wrigge, Jana Heyne, Frieder Kees, David Petroff, Christoph Dorn, Markus Zeitlinger, Charlotte Kloft, David Busse
Publikováno v:
Antibiotics, Vol 9, Iss 931, p 931 (2020)
Antibiotics
Volume 9
Issue 12
Antibiotics
Volume 9
Issue 12
Background: This controlled clinical study aimed to investigate the impact of obesity on plasma and tissue pharmacokinetics of meropenem. Methods: Obese (body mass index (BMI) &ge
35 kg/m2) and age-/sex-matched nonobese (18.5 kg/m2 &ge
BMI
35 kg/m2) and age-/sex-matched nonobese (18.5 kg/m2 &ge
BMI
Autor:
André Schaeftlein, Robin Michelet, Alexander Solms, Wilhelm Huisinga, David Busse, Luis Ilia, Charlotte Kloft, Markus Zeitlinger
Publikováno v:
Pharmaceutical Research
Purpose Systematic comparison of analysis methods of clinical microdialysis data for impact on target-site drug exposure and response. Methods 39 individuals received a 500 mg levofloxacin short-term infusion followed by 24-h dense sampling in plasma